SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000882104-20-000034
Filing Date
2020-03-11
Accepted
2020-03-11 16:19:37
Documents
20
Effectiveness Date
2020-03-11

Document Format Files

Seq Description Document Type Size
1 DEFA14A pdli-20200311defa14adoc.htm DEFA14A 44381
2 PRESS RELEASE pdli-202003118xkex991.htm EX-99.1 383217
3 PRESENTATION pdli-202003118xkex992.htm EX-99.2 7662
4 pdllogoa30.jpg GRAPHIC 123123
5 slide1b19.jpg GRAPHIC 52634
6 slide2b18.jpg GRAPHIC 223230
7 slide3b18.jpg GRAPHIC 181466
8 slide4b18.jpg GRAPHIC 137874
9 slide5b18.jpg GRAPHIC 104787
10 slide6b18.jpg GRAPHIC 120229
11 slide7b18.jpg GRAPHIC 126145
12 slide8b16.jpg GRAPHIC 95648
13 slide9b15.jpg GRAPHIC 169373
14 slidy05.jpg GRAPHIC 177451
15 slidy06.jpg GRAPHIC 113712
16 slidy07.jpg GRAPHIC 102028
17 slidy08b.jpg GRAPHIC 188420
18 slidy09.jpg GRAPHIC 147488
19 slidy10.jpg GRAPHIC 103727
20 slidy11.jpg GRAPHIC 30982
  Complete submission text file 0000882104-20-000034.txt   3465134
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19756 | Film No.: 20705524
SIC: 2836 Biological Products, (No Diagnostic Substances)